Grant: Team Grant: Congenital Heart Disease (CHD) - Care Transitions
University of Alberta
$749,225.00
Optimizing Care Transitions Across the Lifespan in Congenital Heart Disease
EF 2023-24
Résumé
Most children with congenital heart disease (CHD) survive to adulthood. This success story has raised
awareness that survivors of CHD are not cured, and in fact many are at risk of new heart problems
related to their CHD that can appear at any age. Lifelong specialized care is needed, as are transitions
in care from one life stage to the next. These care transitions are typically difficult for patients and
families. Our team has identified three key transition points across the lifespan that need further study:
transition from pediatric to adult healthcare, through pregnancy and into early parenthood, and from
active care to end-of-life care.
Having a lifelong condition like CHD predisposes to anxiety, depression, and social isolation.
Adolescents and young adults have identified that connection with other young people would be helpful
during the move from pediatric to adult care. Our team has developed a peer support program. As part
of this proposal, we will train peer mentors to provide 1-on-1 virtual peer support to mentees age 16-25
years.
pregnancy and into early parenthood. We will develop and evaluate a peer mentor support
program for pregnant women, or for men with CHD whose partner is pregnant.
Unfortunately, persons with CHD have a shortened life span, and benefit from serious illness
conversations with a cardiologist that are appropriately timed and delivered with sensitivity. Our team will
use Canadian data to identify age at death that is specific to a variety of CHD types. This will help
doctors and patients better understand prognosis. We will also identify criteria for initiating serious illness
conversations and develop and evaluate short educational videos designed to train CHD specialists
about these conversations.
Programme
Team Grant: Congenital Heart Disease (CHD) - Care Transitions
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
502842
Name
Mackie Andrew
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Heart and Stroke Foundation of Canada (Ottawa, Ontario)
Prcname2
Special Cases
Projecttitle
Optimizing Care Transitions Across the Lifespan in Congenital Heart Disease
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$749,225
Cihrequipment2
$0
Programname2
Team Grant: Congenital Heart Disease (CHD) - Care Transitions
Keyworddelim
Adolescents; Adult; Congenital; Heart Defects; Lifespan; Mentorship; Parenthood; Pregnancy; Transition Of Care
Abstract
Most children with congenital heart disease (CHD) survive to adulthood. This success story has raised
awareness that survivors of CHD are not cured, and in fact many are at risk of new heart problems
related to their CHD that can appear at any age. Lifelong specialized care is needed, as are transitions
in care from one life stage to the next. These care transitions are typically difficult for patients and
families. Our team has identified three key transition points across the lifespan that need further study:
transition from pediatric to adult healthcare, through pregnancy and into early parenthood, and from
active care to end-of-life care.
Having a lifelong condition like CHD predisposes to anxiety, depression, and social isolation.
Adolescents and young adults have identified that connection with other young people would be helpful
during the move from pediatric to adult care. Our team has developed a peer support program. As part
of this proposal, we will train peer mentors to provide 1-on-1 virtual peer support to mentees age 16-25
years.
pregnancy and into early parenthood. We will develop and evaluate a peer mentor support
program for pregnant women, or for men with CHD whose partner is pregnant.
Unfortunately, persons with CHD have a shortened life span, and benefit from serious illness
conversations with a cardiologist that are appropriately timed and delivered with sensitivity. Our team will
use Canadian data to identify age at death that is specific to a variety of CHD types. This will help
doctors and patients better understand prognosis. We will also identify criteria for initiating serious illness
conversations and develop and evaluate short educational videos designed to train CHD specialists
about these conversations.
Competitiondate
202311
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Mackie, Andrew; Abrahamyan, Lusine; Anthony, Samantha J; Blissett, Sarah; Kaul, Padmaja R; Killackey, Tieghan; Schwerzmann, Markus; Siu, Samuel C; Tam, James W
Approvedterm
5 ans 0 mois
Cihrcontribution2
ICRH~ $749,225~ $0~